ArticleEuropean journal of nuclear medicine and molecular imaging2020

Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course?

Sandip Basu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.